Press Release May 05 2021
Filed with NSE · · 3 pages · English
Summary by 6ix AI
Wipro Limited has issued an updated press release regarding its partnership with Transcell Oncologics to enhance vaccine safety assessment using augmented intelligence. The collaboration aims to improve the safety of global vaccine immunization programs by applying AI to predict adverse effects from vaccinations. This innovative approach replaces traditional animal testing methods and integrates seamlessly into existing workflows in vaccine production. The partnership is expected to lead to safer and more effective vaccines, benefiting researchers and patients alike.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Wipro
- Press Release May 04 2021
- Press Release Apr 29 2021
- Press Release Apr 27 2021
- Press Release Apr 26 2021
- Press Release Apr 23 2021
Later from Wipro
- Press Release May 13 2021
- Press Release May 14 2021
- Press Release May 18 2021
- Press Release Jun 02 2021
- Press Release Jun 03 2021
Follow Wipro into a list and get an email when it puts out news.
Follow Wipro